دورية أكاديمية
1488P Exploring efficacy and safety of immune checkpoint inhibitors (ICI) in extensive stage (ES)- small-cell lung cancer (SCLC) in specific populations: Real-world data from the Durvalumab Expanded Access program Regional European cohort (DEAR)
| العنوان: | 1488P Exploring efficacy and safety of immune checkpoint inhibitors (ICI) in extensive stage (ES)- small-cell lung cancer (SCLC) in specific populations: Real-world data from the Durvalumab Expanded Access program Regional European cohort (DEAR) |
|---|---|
| المؤلفون: | Zer, A., Janzic, U., Daher, S., Unk, M., Moskovitz, M.T., Merimskiy, O., Garrido, P., Lupes, M., Araújo, D., Wollner, M., Sorotsky, H.G., Rotem, O., Urban, D., Chmielewska, I., Barroso, A.M.P. |
| المصدر: | In Annals of Oncology October 2023 34 Supplement 2:S840-S840 |
| قاعدة البيانات: | ScienceDirect |
كن أول من يترك تعليقا!